Twist Bioscience Corp TWST
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Twist Bioscience Achieves LEED Certification for Sustainable Operations and Maintenance
-
Twist Bioscience Releases 2024 Corporate Responsibility Report and Quantifies Carbon Footprint of Oligo Manufacturing Process for NGS Target Enrichment Panels
-
Twist Bioscience to Present at Baird Global Healthcare Conference 2024
-
How A.I. Is Shaping the Future of U.S. Healthcare: Regulatory and Market Updates
-
Twist Bioscience Expands Gene Offering With Long Gene Fragments up to 5.0kb
-
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
-
Twist Bioscience and bitBiome Announce Strategic Collaboration and First Offering to Deliver One-of-a-Kind Enzymes for Biocatalysis
-
Twist Bioscience Reports Fiscal Third Quarter 2024 Financial Results
Trading Information
- Previous Close Price
- $42.79
- Day Range
- $43.17–44.54
- 52-Week Range
- $14.42–60.90
- Bid/Ask
- $40.00 / $46.95
- Market Cap
- $2.54 Bil
- Volume/Avg
- 341,909 / 867,428
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 8.47
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- 0.20%
Company Profile
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of its revenue from the United States.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Core
- Total Number of Employees
- 919
- Website
- https://www.twistbioscience.com
Comparables
Valuation
|
Metric
|
TWST
|
002030
|
688253
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 12.70 | 21.74 |
Price/Book Value | 5.16 | 1.07 | 3.00 |
Price/Sales | 8.47 | 8.73 | 8.86 |
Price/Cash Flow | — | 15.08 | 17.00 |
Price/Earnings
TWST
002030
688253
Financial Strength
|
Metric
|
TWST
|
002030
|
688253
|
|---|---|---|---|
Quick Ratio | 4.36 | 2.15 | 15.40 |
Current Ratio | 4.91 | 4.15 | 15.84 |
Interest Coverage | −235,496.00 | −78.04 | 2,238.82 |
Quick Ratio
TWST
002030
688253
Profitability
|
Metric
|
TWST
|
002030
|
688253
|
|---|---|---|---|
Return on Assets (Normalized) | −18.71% | −5.89% | 12.17% |
Return on Equity (Normalized) | −23.43% | −7.30% | 13.13% |
Return on Invested Capital (Normalized) | −22.10% | −7.42% | 12.68% |
Return on Assets
TWST
002030
688253
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| Lqnyrqlql | Xbcw | $228.7 Bil | |||
| Danaher Corp
DHR
| Ssftrgnnrz | Hdjdcb | $195.0 Bil | |||
| IQVIA Holdings Inc
IQV
| Jyzdqqd | Wpymxb | $41.9 Bil | |||
| Agilent Technologies Inc
A
| Dgyrclvsjc | Fggd | $41.7 Bil | |||
| IDEXX Laboratories Inc
IDXX
| Gydxyhbvcl | Glmtv | $39.3 Bil | |||
| Mettler-Toledo International Inc
MTD
| Vsqjhmmc | Wtdtnvp | $30.8 Bil | |||
| Icon PLC
ICLR
| Nrttrxd | Qyxhz | $24.3 Bil | |||
| Illumina Inc
ILMN
| Xkmkcvz | Rrwfsp | $22.5 Bil | |||
| Waters Corp
WAT
| Htwfzrckf | Csx | $20.9 Bil | |||
| Labcorp Holdings Inc
LH
| Dzjvdqmz | Cgbtwrw | $18.1 Bil |
United States